NASDAQ:SNMX Senomyx (SNMX) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SNMX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.49▼$1.4950-Day Range N/A52-Week Range$0.83▼$1.71VolumeN/AAverage Volume151,720 shsMarket Capitalization$72.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Senomyx alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Senomyx Stock (NASDAQ:SNMX)Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.Read More Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> SNMX Stock News HeadlinesDecember 9, 2023 | morningstar.comAKD Securities Ltd Ordinary Shares AKDSLJuly 19, 2023 | investing.comNZ Automotive Investments Ltd (NZA)April 25, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 30, 2023 | thestreet.comMcKesson Inc. (MCK): Today's Featured Wholesale LaggardFebruary 23, 2023 | usatoday.comFact check: Fetal tissue not in your food, drinks, experts sayJune 2, 2022 | thestreet.comHow to Get Stock Exposure to Gluten-Free MovementJanuary 29, 2022 | fool.comSenomyx, Inc.(SNMX)See More Headlines Receive SNMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:SNMX CUSIPN/A CIK1123979 Webwww.senomyx.com Phone858-646-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,260,000.00 Net Margins-9.11% Pretax MarginN/A Return on Equity-15.80% Return on Assets-10.48% Debt Debt-to-Equity RatioN/A Current Ratio4.35 Quick Ratio3.92 Sales & Book Value Annual Sales$29.32 million Price / Sales2.46 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / Book3.82Miscellaneous Outstanding Shares48,340,000Free FloatN/AMarket Cap$72.03 million OptionableOptionable Beta1.33 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. John W. Poyhonen (Age 58)Pres, CEO & Director Mr. David C. Humphrey (Age 49)VP & CFO Ms. Catherine C. Lee (Age 44)Sr. VP, Gen. Counsel & Corp. Sec. Ms. Sharon Wicker (Age 62)Sr. VP & Chief Commercial Devel. Officer Ms. Susan Firestone MelodyVP of HRKey CompetitorsLee EnterprisesNYSE:LEEMoolec ScienceNASDAQ:MLECVirgin Group Acquisition Corp. IINYSE:VGIIOxus AcquisitionNASDAQ:OXUSGrove CollaborativeNYSE:GROVView All Competitors SNMX Stock Analysis - Frequently Asked Questions How were Senomyx's earnings last quarter? Senomyx, Inc. (NASDAQ:SNMX) posted its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative trailing twelve-month return on equity of 15.80% and a negative net margin of 9.11%. What other stocks do shareholders of Senomyx own? Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX). This page (NASDAQ:SNMX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senomyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
